e-learning
resources
Munich 2006
Monday 04.09.2006
Diagnosis of tuberculosis infection and immunology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
A. Guzel, P. Yildiz, G. Deniz, G. Yillar, V. Yilmaz (Istanbul, Turkey)
Source:
Annual Congress 2006 - Diagnosis of tuberculosis infection and immunology of tuberculosis
Session:
Diagnosis of tuberculosis infection and immunology of tuberculosis
Session type:
Electronic Poster Discussion
Number:
2052
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Guzel, P. Yildiz, G. Deniz, G. Yillar, V. Yilmaz (Istanbul, Turkey). Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 2052
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001
Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 201s
Year: 2007
D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
C-reactive protein in pulmonary TB
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006
Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP)
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
High sensitivity C-reactive protein in asthma
Source: Eur Respir J 2006; 27: 908-912
Year: 2006
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Role of serum adiponectin in COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
Source: Eur Respir J 2005; 25: 688-692
Year: 2005
C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia?
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept